• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床解读血糖控制和血糖变异性的质量指数。

Clinical interpretation of indices of quality of glycemic control and glycemic variability.

机构信息

Biomedical Informatics Consultants, LLC, Potomac, MD 20854-4721, USA.

出版信息

Postgrad Med. 2011 Jul;123(4):107-18. doi: 10.3810/pgm.2011.07.2310.

DOI:10.3810/pgm.2011.07.2310
PMID:21680995
Abstract

The practicing physician is faced with the task of interpreting>2 dozen indices of quality of glycemic control and glycemic variability. It would be desirable to have reference data from relevant patient populations (eg, patients with the same type of diabetes, duration of diabetes, therapeutic regimen, or glycated hemoglobin [HbA1c] levels). The physician can then select the appropriate reference set for interpretation of results for each patient. Institutions and clinics may wish to develop their own reference data. Results can be interpreted as excellent, good, fair, or poor, corresponding with quartiles of their distributions. Each index of glycemic control and variability can be given a numerical score in terms of its percentile within the selected reference population. One can then compute the mean and standard deviation of the percentile scores to obtain an integrated measure of the quality of glycemic control or variability. We calculated quartiles for measures of quality of glycemic control and variability. One can use the percent coefficient of variation (%CV) with criteria that apply irrespective of the HbA1c level as a general rule for interpretation of glycemic variability. For example, a %CV<33.5% can be regarded as excellent, a %CV between 33.5% to 36.8% as good, a %CV between 36.8% to 40.6% as fair, and a %CV>40.6% as poor. A graphical display can be used to make more accurate assessments for narrow HbA1c ranges, as the percentiles of the %CV can change systematically with HbA1c level or with mean glucose level.

摘要

临床医生面临着解读 20 多种血糖控制和变异性质量指数的任务。最好能有来自相关患者群体的参考数据(例如,患有相同类型糖尿病、糖尿病持续时间、治疗方案或糖化血红蛋白 [HbA1c] 水平的患者)。然后,医生可以为每个患者选择适当的参考组来解释结果。医疗机构和诊所可能希望制定自己的参考数据。结果可以解释为优秀、良好、一般或差,与分布的四分位间距相对应。血糖控制和变异性的每个指数都可以根据其在所选参考人群中的百分位数获得数值评分。然后,可以计算百分位数评分的平均值和标准差,以获得血糖控制或变异性质量的综合衡量指标。我们计算了血糖控制和变异性质量的四分位数。%CV(变异系数)可作为一种普遍规则,无论 HbA1c 水平如何,都可以使用该规则来解释血糖变异性。例如,%CV<33.5%可以视为优秀,%CV 在 33.5%至 36.8%之间视为良好,%CV 在 36.8%至 40.6%之间视为一般,%CV>40.6%视为差。可以使用图形显示来更准确地评估 HbA1c 范围较窄的情况,因为%CV 的百分位数会随着 HbA1c 水平或平均血糖水平的变化而系统地变化。

相似文献

1
Clinical interpretation of indices of quality of glycemic control and glycemic variability.临床解读血糖控制和血糖变异性的质量指数。
Postgrad Med. 2011 Jul;123(4):107-18. doi: 10.3810/pgm.2011.07.2310.
2
THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.CGM 衍生参数在 1 型糖尿病中的附加和解释价值取决于血糖控制水平。
Endocr Pract. 2021 Jan;27(1):44-50. doi: 10.4158/EP-2020-0293. Epub 2020 Nov 18.
3
Beyond HbA1c: Comparing Glycemic Variability and Glycemic Indices in Predicting Hypoglycemia in Type 1 and Type 2 Diabetes.超越 HbA1c:在预测 1 型和 2 型糖尿病低血糖中比较血糖变异性和血糖指数。
Diabetes Technol Ther. 2018 May;20(5):353-362. doi: 10.1089/dia.2017.0388. Epub 2018 Apr 24.
4
The different methods of assessing glycemic variability, quality of glycemic control and glycemic risk cannot be interpreted as equivalent in clinical practice.在临床实践中,评估血糖变异性、血糖控制质量和血糖风险的不同方法不能被视为等同。
Diabetes Metab Syndr. 2018 Jul;12(4):555-561. doi: 10.1016/j.dsx.2018.03.028. Epub 2018 Mar 28.
5
Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes.糖化血红蛋白与 2 型糖尿病患者不同血糖变异性程度全因死亡率的相关性。
J Clin Endocrinol Metab. 2021 Oct 21;106(11):3160-3167. doi: 10.1210/clinem/dgab532.
6
Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study.使用连续血糖监测评估血糖变异性:可靠性、参考值以及与既定血糖指标的相关性——马斯特里赫特研究。
Diabetes Technol Ther. 2020 May;22(5):395-403. doi: 10.1089/dia.2019.0385. Epub 2020 Jan 17.
7
Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.定义 1 型糖尿病患者的高血糖变异性:比较多种指标以识别低血糖风险患者。
Diabetes Technol Ther. 2019 Aug;21(8):430-439. doi: 10.1089/dia.2019.0075. Epub 2019 Jun 20.
8
Role of Composite Glycemic Indices: A Comparison of the Comprehensive Glucose Pentagon Across Diabetes Types and HbA1c Levels.复合血糖指标的作用:不同糖尿病类型和糖化血红蛋白水平下全面血糖五边形的比较。
Diabetes Technol Ther. 2020 Feb;22(2):103-111. doi: 10.1089/dia.2019.0277. Epub 2019 Oct 1.
9
Long-term glycemic variability and the risk of mortality in diabetic patients receiving peritoneal dialysis.长期血糖变异性与接受腹膜透析的糖尿病患者死亡风险的关系。
PLoS One. 2022 Jan 25;17(1):e0262880. doi: 10.1371/journal.pone.0262880. eCollection 2022.
10
Relationship between daily and visit-to-visit glycemic variability in patients with type 2 diabetes.2 型糖尿病患者的日常和就诊间血糖变异性之间的关系。
Endocr J. 2020 Aug 28;67(8):877-881. doi: 10.1507/endocrj.EJ20-0012. Epub 2020 May 8.

引用本文的文献

1
A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target.一种基于持续葡萄糖监测的模型,用于预测目标范围内血糖波动达标(TIR)的2型糖尿病患者的低血糖情况。
Diabetol Metab Syndr. 2025 May 24;17(1):169. doi: 10.1186/s13098-025-01713-9.
2
Machine Learning-Based Time in Patterns for Blood Glucose Fluctuation Pattern Recognition in Type 1 Diabetes Management: Development and Validation Study.基于机器学习的1型糖尿病管理中血糖波动模式识别的模式时间:开发与验证研究
JMIR AI. 2023 May 26;2:e45450. doi: 10.2196/45450.
3
Optimal Coefficient of Variance Threshold to Minimize Hypoglycemia Risk in Individuals with Well-Controlled Type 1 Diabetes Mellitus.
优化变异系数阈值以降低血糖控制良好的 1 型糖尿病患者的低血糖风险。
Diabetes Metab J. 2024 May;48(3):429-439. doi: 10.4093/dmj.2023.0083. Epub 2024 Mar 4.
4
Assessing the temporal within-day glycemic variability during hospitalization in patients with type 2 diabetes patients using continuous glucose monitoring: a retrospective observational study.使用连续血糖监测评估2型糖尿病患者住院期间日内血糖的时间变异性:一项回顾性观察研究。
Diabetol Metab Syndr. 2024 Mar 1;16(1):56. doi: 10.1186/s13098-024-01269-0.
5
A systematic bibliometric analysis on the clinical practice of CGM in diabetes mellitus from 2012 to 2022.2012 年至 2022 年糖尿病患者连续血糖监测的临床实践的系统文献计量分析。
Front Endocrinol (Lausanne). 2023 Sep 22;14:1229494. doi: 10.3389/fendo.2023.1229494. eCollection 2023.
6
Association between inpatient glycemic variability and COVID-19 mortality: a prospective study.住院患者血糖变异性与新冠病毒疾病死亡率之间的关联:一项前瞻性研究。
Diabetol Metab Syndr. 2023 Sep 11;15(1):185. doi: 10.1186/s13098-023-01157-z.
7
A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials.住院临床试验中连续血糖监测指标的共识声明。
J Diabetes Sci Technol. 2023 Nov;17(6):1527-1552. doi: 10.1177/19322968231191104. Epub 2023 Aug 17.
8
Prognostic Significance of Baseline Blood Glucose Levels and Glucose Variability in Severe Acute Kidney Injury: A Secondary Analysis from the RENAL Study.严重急性肾损伤患者基线血糖水平及血糖变异性的预后意义:来自RENAL研究的二次分析
J Clin Med. 2022 Dec 20;12(1):15. doi: 10.3390/jcm12010015.
9
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study.葡萄糖变异性与不良血管状况有关,但仅在 1 型糖尿病患者存在胰岛素抵抗的情况下如此:一项观察性研究。
Diab Vasc Dis Res. 2022 May-Jun;19(3):14791641221103217. doi: 10.1177/14791641221103217.
10
Comparison of Glycemic Variability and Hypoglycemic Events in Hospitalized Older Adults Treated with Basal Insulin plus Vildagliptin and Basal-Bolus Insulin Regimen: A Prospective Randomized Study.基础胰岛素联合维格列汀与基础-餐时胰岛素方案治疗老年住院患者的血糖变异性和低血糖事件比较:一项前瞻性随机研究
J Clin Med. 2022 May 16;11(10):2813. doi: 10.3390/jcm11102813.